Koers Paxman AB (publ) Nasdaq Stockholm
Aandelen
SE0009806284
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 292 mln. 27,79 mln. 25,95 mln. | Omzet 2025 * | 401 mln. 38,16 mln. 35,64 mln. | Marktkapitalisatie | 888 mln. 84,5 mln. 78,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 34 mln. 3,24 mln. 3,02 mln. | Nettowinst (verlies) 2025 * | 84 mln. 7,99 mln. 7,47 mln. | EV/omzet 2024 * | 2,9 x |
Nettoliquiditeiten 2024 * | 42 mln. 4 mln. 3,73 mln. | Nettoliquiditeiten 2025 * | 97 mln. 9,23 mln. 8,62 mln. | EV/omzet 2025 * | 1,97 x |
K/w-verhouding 2024 * |
25,9
x | K/w-verhouding 2025 * |
10,6
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 35,76% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 20-12-16 |
Director of Finance/CFO | 44 | 01-03-20 | |
Emma Thornhill
DFI | Director of Finance/CFO | 39 | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 01-12-16 |
Chairman | 70 | 01-12-16 | |
Maria Bech
BRD | Director/Board Member | 56 | 20-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,81% | 180 mld. | |
-1,63% | 106 mld. | |
-4,14% | 67,55 mld. | |
-6,56% | 46,11 mld. | |
+13,22% | 45,79 mld. | |
+6,13% | 41,61 mld. | |
+19,93% | 31,07 mld. | |
+13,61% | 24,77 mld. | |
-5,36% | 24,27 mld. |